000 | 01284 a2200337 4500 | ||
---|---|---|---|
005 | 20250514011542.0 | ||
264 | 0 | _c20011204 | |
008 | 200112s 0 0 eng d | ||
022 | _a1523-6838 | ||
024 | 7 |
_a10.1053/ajkd.2001.27391 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aSunder-Plassmann, G | |
245 | 0 | 0 |
_aEffect of erythropoietin on cardiovascular diseases. _h[electronic resource] |
260 |
_bAmerican journal of kidney diseases : the official journal of the National Kidney Foundation _cOct 2001 |
||
300 |
_aS20-5 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Review | ||
650 | 0 | 4 |
_aAnemia _xdrug therapy |
650 | 0 | 4 |
_aCardiovascular Diseases _xepidemiology |
650 | 0 | 4 | _aComorbidity |
650 | 0 | 4 |
_aErythropoietin _xadverse effects |
650 | 0 | 4 | _aHematocrit |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aHypertension _xchemically induced |
650 | 0 | 4 | _aIncidence |
650 | 0 | 4 |
_aKidney Failure, Chronic _xepidemiology |
650 | 0 | 4 | _aRecombinant Proteins |
650 | 0 | 4 | _aRenal Dialysis |
700 | 1 | _aHörl, W H | |
773 | 0 |
_tAmerican journal of kidney diseases : the official journal of the National Kidney Foundation _gvol. 38 _gno. 4 Suppl 1 _gp. S20-5 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1053/ajkd.2001.27391 _zAvailable from publisher's website |
999 |
_c11498517 _d11498517 |